Inclusion of Kintor as a Constituent Stock of HSCI
SUZHOU, China, Aug. 22, 2021 /PRNewswire/ — Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company’s stock has…
